Academic medical centers in the US are voicing concern over reduced funding from the National Institutes of Health (NIH). While the issue is domestic, its effects may be global.
These institutions are key drivers of innovation far beyond the US, often laying the foundation for diagnostics, AI in healthcare, and advanced imaging breakthroughs. When public funding slows, private innovation can follow — across borders.
At Axcellant, we closely follow these developments, recognizing how early-stage research shapes the future of clinical advancements worldwide.
Explore how we support global innovation through smarter trial strategies.
Axcellant, a specialist global contract research organization (CRO), has been appointed by Switzerland-based Santersus AG to support the execution of…
Axcellant will participate in the Annual Congress of the European Association of Nuclear Medicine (EANM 2026), taking place from 17…
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
Copyright @ 2026 Axcellant|Privacy Policy|Cookie Policy|